Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: Do Standard Toxicology Parameters Match Clinical Needs for Immune Check-point Inhibitors in Liver Cancer Therapy?

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 30 Jun 2022

Guest Editor(s)

  • Giuliano Ramadori, MD
    Professor of medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.

    Website | E-mail

  • Alessandro Ortenzi
    Doctor, Phase 1 Clinical Trials QA Coordinator - Ospedali Riuniti Ancona - Umberto I G.M. Lancisi G. Salesi, Clinical Trial Quality Assurance, United Hospitals of Ancona, Ancona, Marches, Italy.

    Website | E-mail

Submission Deadline

30 Jun 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 30 June 2022
Contacts: Victoria Lee, Assistant Editor,

Published Articles

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties